Who
Braden Michael Leonard
10% owner
Company insider
Files Form 4 as: 10% owner, Outset Medical; 10% owner, Aclaris Therapeutics; 10% owner, Adverum Biotechnologies; 10% owner, Astrotech; 10% owner, AN2 Therapeutics; 10% owner and Other, OnKure Therapeutics; 10% owner, Talis Biomedical; 10% owner and Other, Tectonic Therapeutic.
In numbers
- Trades disclosed
- 238
- Buys
- 139
- Sells
- 70
- Bought
- $32.4M
- Sold
- $51.2M
- Companies
- 16
- Companies where not an officer
- 16
- First trade
- 28 Apr 2011
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Bought | $64K16,575 at $3.88 | filing |
| 1 Oct 2026filed 5 Oct 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Bought | $806K228,334 at $3.53 | filing |
| 15 May 2026filed 18 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $1.6M323,000 at $5.00 | filing |
| 15 May 2026filed 18 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $1.6M323,000 at $5.00 | filing |
| 11 May 2026filed 12 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $485K96,900 at $5.00 | filing |
| 11 May 2026filed 12 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $485K96,900 at $5.00 | filing |
| 8 May 2026filed 12 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $988K197,600 at $5.00 | filing |
| 8 May 2026filed 12 May 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code X | $988K197,600 at $5.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.4M300,000 at $4.53 | filing |
| 23 Apr 2026filed 27 Apr 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.4M300,000 at $4.53 | filing |
| 4 Dec 2025filed 5 Dec 2025 | Adverum Biotechnologies | SEC FORM 4 Sold | $2.2M524,560 at $4.19 | filing |
| 3 Dec 2025filed 3 Dec 2025 | Adverum Biotechnologies | SEC FORM 4 Sold | $930K222,925 at $4.17 | filing |
| 2 Dec 2025filed 3 Dec 2025 | Adverum Biotechnologies | SEC FORM 4 Sold | $218K51,961 at $4.20 | filing |
| 1 Dec 2025filed 3 Dec 2025 | Adverum Biotechnologies | SEC FORM 4 Sold | $1.3M300,000 at $4.20 | filing |
| 3 Oct 2025filed 7 Oct 2025 | ASTC AstrotechLife-science tools | SEC FORM 4 Sold | $1.6M220,410 at $7.13 | filing |
| 3 Oct 2025filed 7 Oct 2025 | ASTC AstrotechLife-science tools | SEC FORM 4 Sold | $53K9,166 at $5.83 | filing |
| 30 May 2025filed 30 May 2025 | ANTX AN2 TherapeuticsBiotechnology | SEC FORM 4 Sold | $429K425,000 at $1.01 | filing |
| 30 May 2025filed 30 May 2025 | ANTX AN2 TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,2107,000 at $1.03 | filing |
| 28 May 2025filed 16 Jun 2025 | ANTX AN2 TherapeuticsBiotechnology | SEC FORM 4 Sold | $218K200,000 at $1.09 | filing |
| 28 May 2025filed 30 May 2025 | ANTX AN2 TherapeuticsBiotechnology | SEC FORM 4 Sold | $2.3M2,000,000 at $1.16 | filing |
News
Head-To-Head Contrast: Femasys (NASDAQ:FEMY) versus Outset Medical (NASDAQ:OM)OM · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Braden Michael Leonard; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.